231 related articles for article (PubMed ID: 32691244)
1. Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.
Hsieh CY; Tsai TF
Clin Drug Investig; 2020 Oct; 40(10):915-926. PubMed ID: 32691244
[TBL] [Abstract][Full Text] [Related]
2. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
3. Colony-stimulating factors for the management of neutropenia in cancer patients.
Dale DC
Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
[TBL] [Abstract][Full Text] [Related]
4. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
Carrato A; Guillén-Ponce C; Grande-Pulido E
Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
[TBL] [Abstract][Full Text] [Related]
5. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
6. Review of granulocyte colony-stimulating factors in the treatment of established febrile neutropenia.
Pérez Velasco R
J Oncol Pharm Pract; 2011 Sep; 17(3):225-32. PubMed ID: 20562168
[TBL] [Abstract][Full Text] [Related]
7. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.
Freyer G; Ligneau B; Trillet-Lenoir V
Int J Antimicrob Agents; 1998 Apr; 10(1):3-9. PubMed ID: 9624538
[TBL] [Abstract][Full Text] [Related]
8. Pustular eruption associated with granulocyte colony-stimulating factor treatment.
Brumana MB; Russo I; Zambello R; Alaibac M
G Ital Dermatol Venereol; 2018 Apr; 153(2):276-277. PubMed ID: 27845511
[TBL] [Abstract][Full Text] [Related]
9. Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit?
Pick AM; Nystrom KK
J Pharm Pract; 2014 Oct; 27(5):447-52. PubMed ID: 25124379
[TBL] [Abstract][Full Text] [Related]
10. Myeloid growth factors.
Crawford J; Armitage J; Balducci L; Bennett C; Blayney DW; Cataland SR; Dale DC; Demetri GD; Erba HP; Foran J; Freifeld AG; Goemann M; Heaney ML; Htoy S; Hudock S; Kloth DD; Kuter DJ; Lyman GH; Michaud LB; Miyata SC; Tallman MS; Vadhan-Raj S; Westervelt P; Wong MK;
J Natl Compr Canc Netw; 2009 Jan; 7(1):64-83. PubMed ID: 19176207
[No Abstract] [Full Text] [Related]
11. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced myelosuppression : diagnosis and management.
Carey PJ
Drug Saf; 2003; 26(10):691-706. PubMed ID: 12862504
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
Johnston EM; Crawford J
Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
[TBL] [Abstract][Full Text] [Related]
15. Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.
Ricotta R; Cerea G; Schiavetto I; Maugeri MR; Pedrazzoli P; Siena S
Future Oncol; 2006 Dec; 2(6):667-76. PubMed ID: 17155894
[TBL] [Abstract][Full Text] [Related]
16. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
[TBL] [Abstract][Full Text] [Related]
17. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
18. Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM).
Tralongo AC; Antonuzzo A; Pronzato P; Sbrana A; Turrini M; Zoratto F; Danova M
Tumori; 2020 Aug; 106(4):273-280. PubMed ID: 32538316
[TBL] [Abstract][Full Text] [Related]
19. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
Ersbøll J
Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
[No Abstract] [Full Text] [Related]
20. [Use of granulocyte growth factors: recommendations of the Portuguese Society of Hematology].
Forjaz de Lacerda J; Leal da Costa F; Marques Pereira A; Príncipe F; Teixeira A; Parreira A;
Acta Med Port; 2008; 21(5):412-26. PubMed ID: 19187683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
